Psycheceutical Bioscience

Shark Tank’s Kevin Harrington thinks safe psychedelic medicines without the “trip” are the future of mental health care, and has put his support behind Psycheceutical - Click Here To Invest Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a biotechnology company developing...

Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the recent Benzinga Psychedelics Capital Conference in Miami. He also...

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a biotechnology company developing a new and unique mode of administration that has the potential...

Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a biotechnology company with patented technology that says it aims to revolutionize the psychedelic mental health space and disrupt Big Pharma. The company is developing a topical cream administration of ketamine to allow the drug to directly target...

When the average person thinks about psychedelics, it is easy to conjure up a picture of a trippy experience with hallucinogenic visions, and ‘Lucy In The Sky With Diamonds’ playing in the background. And if you aren’t familiar with the nuanced discussions that have recently...

Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. The company develops cutting-edge gear and novel compounds for next-gen mental health...